HCG share price has declined by 30% in the past three months and 38% since our downgrade in February, 2018 and the recent correction offers another opportunity to take a positive view on the stock.

HCG’s performance was decent with recovery promising. Its Q1FY21 revenues and ebitda declined 28% and 57% YoY, respectively. Lower costs led to ebitda exceeding our estimates by 29%. Recovery trends ...

The Food and Drug Administration (FDA) has approved hCG injections to treat specific medical conditions. In females assigned at birth (FAABs), they can help treat infertility. In males assigned at ...

Hi. I am looking for HCG for injection (Pregnyl, Novarel, Profasi etc) & am finding it impossible to find. Even more impossible to find is bacteriostatic water for injection (not sterile water because ...